ReShape Lifesciences™ to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate Update
March 17, 2022 09:07 ET
|
ReShape Lifesciences Inc
Full Year Revenue Increased by Approximately 20%, from $11.3 M to $13.6 M $22.8 M in Cash and Cash Equivalents as of December 31, 2021 Company Eliminated All Debt from Balance Sheet Webcast to be...
ReShape Lifesciences to Participate in Investor Conferences in March
March 09, 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced...
ReShape Lifesciences™ to Participate in the American Society for Metabolic and Bariatric Surgery’s (ASMBS) Leadership Academy and re-UNITED Meeting January 19-22, 2022 in Las Vegas
January 18, 2022 08:30 ET
|
ReShape Lifesciences Inc
Company to Present and Exhibit its Next-Generation Lap-Band® Program Including its Supportive reshapecare™ Virtual Health Coaching Platform Shelly Russell, Vice President Field Operations of ReShape...
ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operations
January 13, 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the...
ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign
November 16, 2021 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, previously announced...
ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results
November 11, 2021 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported its...
ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021
November 08, 2021 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced today that it...
ReShape Lifesciences™ to Launch Line of ProCare Health® Supplements to Meet Consumers’ Nutritional Needs
November 04, 2021 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the...
ReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conference
October 19, 2021 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced Thomas...
ReShape Launches National Advertising Campaign for Flagship Product, Lap-Band®
October 12, 2021 08:00 ET
|
ReShape Lifesciences Inc
The Company’s first and largest mainstream mass-market advertising campaign Featured on major television channels and consumer print publications SAN CLEMENTE, Calif., Oct. 12, 2021 (GLOBE...